QSAR analysis of cyclooxygenase inhibitor using particle swarm optimization and multiple linear regression.
暂无分享,去创建一个
Guo-Li Shen | Ru-Qin Yu | Jian-Hui Jiang | Jian-hui Jiang | G. Shen | R. Yu | Qi Shen | Qi Shen | Jian-Xia Lü | Jian-Xia Lü
[1] Guo-Li Shen,et al. Variable selection by an evolution algorithm using modified Cp based on MLR and PLS modeling: QSAR studies of carcinogenicity of aromatic amines , 2003, Analytical and bioanalytical chemistry.
[2] F. Cabré,et al. Stereoselective Inhibition of Inducible Cyclooxygenase by Chiral Nonsteroidal Antiinflammatory Drugs , 1996, Journal of clinical pharmacology.
[3] D. Riendeau,et al. Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. , 1996, Gastroenterology.
[4] C. Koboldt,et al. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents. , 1997, Journal of medicinal chemistry.
[5] K. Seibert,et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] B. Varnum,et al. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.
[7] C. Thiemermann,et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Gierse,et al. A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors* , 1996, The Journal of Biological Chemistry.
[9] K. Seibert,et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Jurs,et al. Development and use of charged partial surface area structural descriptors in computer-assisted quantitative structure-property relationship studies , 1990 .
[11] R. Schoen,et al. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. , 1989, The American journal of medicine.
[12] J. Vane,et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Erikson,et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] V. Winn,et al. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. , 1991, The Journal of biological chemistry.
[15] C. Torrance,et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.
[16] Yoshikazu Fukuyama,et al. A particle swarm optimization for reactive power and voltage control considering voltage security assessment , 2000 .
[17] C. Patrono,et al. The clinical significance of inhibition of renal prostaglandin synthesis. , 1987, Kidney international.
[18] D. Dewitt,et al. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.
[19] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[20] James Kennedy,et al. Particle swarm optimization , 2002, Proceedings of ICNN'95 - International Conference on Neural Networks.
[21] K. Seibert,et al. Role of inducible cyclooxygenase (COX-2) in inflammation. , 1994, Receptor.
[22] D M Clive,et al. Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.